Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-22 Tax Withholding | 2023-05-24 5:04 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 691 | $1.45 | 37,188 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:28 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $2.88 | 65,388 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:28 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 65,388 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 2,012 | $2.88 | 82,084 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 5,814 | $0 | 82,084 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 860 | $2.88 | 38,826 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,484 | $0 | 38,826 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,417 | $2.88 | 63,766 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 63,766 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-05 5:10 pm | N/A 2033-04-03 | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 7,500,000 | $0 | 7,500,000 (Direct) | View |
Ownership | 2023-03-02 4:13 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | KOTLER KEVIN Director | 0 | $0 | 805,151 (Direct) | View |
Ownership | 2023-03-02 4:11 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Director | 0 | $0 | 265,151 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 7:20 pm | N/A 2033-02-22 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam See Notes 2 & 3 | 265,151 | $0 | 4,765,151 (Direct) | View |
Ownership | 2023-02-08 6:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 | 0 | $0 | 4,500,000 (Indirect) | View |
Ownership | 2023-02-08 6:23 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim See Footnote 1 | 0 | $0 | 11,750,000 (Indirect) | View |
| 2023-01-18 Option Award | 2023-01-20 5:10 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 49,788 | $0 | 49,788 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:10 pm | N/A 2033-01-18 | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:09 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 66,385 | $0 | 66,385 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:09 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 42,631 | $0 | 42,631 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 149,365 | $0 | 149,365 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:37 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $3.17 | 69,054 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:37 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 69,054 (Direct) | View |
| 2022-10-31 Other | 2023-01-17 5:37 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 1,654 | $3.2725 | 69,054 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.17 | 319,972 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,767 | $0 | 319,972 (Direct) | View |
| 2022-10-31 Other | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 1,655 | $3.2725 | 319,972 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 2,012 | $3.17 | 84,096 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 5,814 | $0 | 84,096 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:35 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 1,013 | $3.17 | 39,686 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:35 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,485 | $0 | 39,686 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.17 | 66,838 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 66,838 (Direct) | View |
| 2022-10-31 Other | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,655 | $3.2725 | 66,838 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:22 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 115,740 | $0 | 129,392 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:21 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director | 115,740 | $0 | 132,442 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:20 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 115,740 | $0 | 129,032 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:20 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 115,740 | $0 | 132,442 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:19 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 115,740 | $0 | 129,192 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 67,758 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $3.76 | 67,758 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 321,881 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.76 | 321,881 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:37 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 5,814 | $0 | 86,108 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:37 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 2,012 | $3.76 | 86,108 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,485 | $0 | 40,699 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 861 | $3.76 | 40,699 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 65,540 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.76 | 65,540 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:23 pm | N/A 2032-07-25 | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 165,961 | $0 | 165,961 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:22 pm | N/A 2032-07-25 | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 165,961 | $0 | 165,961 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:21 pm | N/A 2032-07-25 | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 60,902 | $0 | 60,902 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:21 pm | N/A 2032-07-25 | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 165,961 | $0 | 165,961 (Direct) | View |
| 2022-04-29 Other | 2022-07-15 4:58 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 1,505 | $3.842 | 71,275 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:58 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 71,275 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:58 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $3.01 | 71,275 (Direct) | View |
| 2022-04-29 Other | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 1,504 | $3.842 | 328,604 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 328,604 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.01 | 328,604 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:56 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 5,814 | $0 | 88,120 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:56 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 2,012 | $3.01 | 88,120 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,485 | $0 | 41,560 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 860 | $3.01 | 41,560 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 67,552 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.01 | 67,552 (Direct) | View |